Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: A single-center cohort of 1,248 patients with Gleason 7 tumors

World Journal of Urology

Volumn 29, Issue 5, 2011, Pages 671-676

  Alenda, Olivier ^a   Ploussard, Guillaume ^a   Mouracade, Pascal ^a   Xylinas, Evanguelos ^a   de la Taille, Alexandre ^a   Allory, Yves ^a   Vordos, Dimitri ^a   Hoznek, Andras ^a   Abbou, Claude Clement ^a   Salomon, Laurent ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Biochemical recurrence free survival; Primary Gleason; Prostate neoplasm; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER GRADING; DISEASE FREE SURVIVAL; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; PROSTATECTOMY;

ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 80053899058     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0620-9     Document Type: Article

References (17)

1. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC et al (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retro pubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28: 555-565.
2. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
3. Epstein JI, Partin AW, Sauvageot J et al (1996) Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20: 286-292.
4. Tefilli MV, Gheiler EL, Tiguert R, Sakr W, Grignon DJ, Banerjee M, Pontes JE, Wood DP Jr et al (1999) Should Gleason score 7 prostate cancer be considered a unique grade category? Urology 53: 372-377.
5. Sakr WA, Tefilli MV, Grignon DJ, Banerjee M, Dey J, Gheiler EL, Tiguert R, Powell IJ, Wood DP et al (2000) Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology 56: 730-734.
6. Rasiah KK, Stricker PD, Haynes AM, Delprado W, Turner JJ, Golovsky D, Brenner PC, Kooner R, Henshall SM et al (2003) Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma. Cancer 98: 2560-2565.
7. Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Mucci LA et al (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27: 3459-3464.
8. Epstein JI, Pound CR, Partin AW, Walsh PC et al (1998) Disease progression following radical prostatectomy in men with Gleason score 7 tumor. J Urol 160: 97-100.
9. Herman CM, Kattan MW, Ohori M, Scardino PT, Wheeler TM et al (2001) Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy. Am J Surg Pathol 25: 657-660.
10. Sim HG, Telesca D, Culp SH et al. (2008) Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence. J Urol 179: 1775.
11. Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC et al (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523.
12. Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL et al (2009) Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumours in a population based cohort. J Urol 182: 2702-2707.
13. Guimaraes MS, Quintal MM, Meirelles LR, Magna LA, Ferreira U, Billis A et al (2008) Gleason score as predictor of clinicopathologic findings and biochemical (PSA) progression following radical prostatectomy. Int Braz J Urol 34: 23-29.
14. Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Koeneman KS et al (2004) Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy. BJU Int 94: 42-46.
15. Amling CL, Blute ML, Bergstralh EJ, Seay TM, Slezak J, Zincke H et al (2000) Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 164: 101-105.
16. Chan TY, Partin AW, Walsh PC, Epstein JI et al (2000) Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology 56: 823-827.
17. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW et al (2006) Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 176: 1404-1408.